Example: Heart Attack
Clinical Trials on Lice Infestations
Total 3 results
-
NCT00244439CompletedConditions: Lice Infestations
-
NCT00291057TerminatedConditions: Lice Infestations
-
NCT00819520CompletedConditions: Lice Infestations
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- Chronic Critical Limb Ischemia
- Congenital Dyserythropoietic Anemia (CDA)
- Gastric Cancer Third Line
- Hernia Direct
- Hypnotic Intoxication
- Integrated Advanced Information Management Systems
- Outcome Assessments (Health Care)
- Parathyroid Carcinoma
- Post-exposure Prophylaxis
- Pseudoexfoliation Glaucoma in Both Eyes
- Seborrhoeic Dermatitis of the Scalp
- Well Being
- Young Adults
- View Full List
Sponsors and Collaborators
- Antelope Valley Partners for Health
- Asian Development Bank Japan Scholarship Program
- Christian Candrian
- Clinica Santa maria del Lago
- Dr. Karin Neukam
- Fernandes Tavora Hospital
- Gozdem Kayki
- Leortec Medical Systems Ltd
- Lipid and Cardiovascular Risk Assessment Service, ICPMR, Westmead Hospital
- Listen Trial Group
- Nepal Medical College and Teaching Hospital
- Niche Science & Technology Ltd
- Zahnklinik Bochum, Augusta Hospital (Prof. Dr. Peter Jöhren)
- View Full List
Drug Interventions
- 2% guttae ganciclovir
- Aprepitant 200mg
- Bepreve
- Butorphanol and Propofol
- CeraVe Hydrating Cleanser
- Cetirizine Hydrochloride 1 MG/ML
- Fatty Acids, Unsaturated
- Fluid bolus administration
- JLP-1207(Fed)
- M6223
- VT-1161 150 mg capsule
- bimatoprost 0.03% ophthalmic solution; hypromellose 0.2% eyedrops
- iNO
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations